Observational Study for Lung Cancer Patients Treated With Nivolumab
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Healthy Participants Evaluating the Absorption of a BMS-986205 Tablet Into the Bloodstream Compared to a Reference Tablet
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different Processes
- Status
- COMPLETED
- Phase
- PHASE1
Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Bioavailability of BMS-986205
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Regimens
- Status
- COMPLETED
- Phase
- N/A
Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet
- Status
- COMPLETED
- Phase
- PHASE1
LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
- Status
- COMPLETED
- Phase
- PHASE2
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy
- Status
- COMPLETED
- Phase
- PHASE2
MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
- Status
- TERMINATED
- Phase
- PHASE2